EXH 12 Pill: yellow, round
The pill with imprint EXH 12 (Yellow, Round, 0mm) has been identified as Hydromorphone Hydrochloride Extended-Release 12 mg and is used for Chronic Pain, Pain, Anesthetic Adjunct, and Cough. It belongs to the drug class Opioids (narcotic analgesics) and is classified as CSA Schedule 2 (High potential for abuse).
Images for EXH 12


Hydromorphone Hydrochloride Extended-Release
- Imprint
- EXH 12
- Strength
- 12 mg
- Color
- Yellow
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Opioids (narcotic analgesics)
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- 2 - High potential for abuse
- Labeler / Supplier
- Mallinckrodt Medical Inc
- Inactive Ingredients
-
butylated hydroxytoluene,
cellulose acetate,
ferrosoferric oxide,
ferric oxide yellow,
hypromellose 2910 (5 mPa.s),
lactose anhydrous,
lactose monohydrate,
magnesium stearate,
sodium chloride,
titanium dioxide,
triacetin
Note: Inactive ingredients may vary.
Labelers / Repackagers
NDC Code | Labeler / Repackager |
---|---|
00406-3312 (Discontinued) | Mallinckrodt Inc. |
23635-0412 (Discontinued) | Mallinckrodt Inc. |
35356-0608 | Lake Erie Medical and Surgical Supply (repackager) |
Related images for "EXH 12"
More about hydromorphone
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (450)
- Drug images
- Latest FDA alerts (12)
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- Drug class: Opioids (narcotic analgesics)
- Breastfeeding
Patient resources
- Hydromorphone drug information
- Hydromorphone injection
- Hydromorphone rectal
- Hydromorphone Extended-Release Tablets
- Hydromorphone Liquid
Other brands
Dilaudid, Exalgo, Dilaudid-HP, Palladone
Professional resources
- Hydromorphone Hydrochloride monograph
- Hydromorphone (FDA)
- Hydromorphone Extended Release (FDA)
- Hydromorphone Injection (FDA)
- Hydromorphone Oral Solution (FDA)
Other brands
Dilaudid, Exalgo, Dilaudid-HP, Palladone
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.